This company has been marked as potentially delisted and may not be actively trading.

SHL Telemedicine (SHLT) Competitors

SHLT vs. EQ, IMUX, EDAP, ACOG, and APYX

Should you be buying SHL Telemedicine stock or one of its competitors? The main competitors of SHL Telemedicine include Equillium (EQ), Immunic (IMUX), Edap Tms (EDAP), Alpha Cognition (ACOG), and Apyx Medical (APYX). These companies are all part of the "medical" sector.

How does SHL Telemedicine compare to Equillium?

SHL Telemedicine (NASDAQ:SHLT) and Equillium (NASDAQ:EQ) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations, earnings and media sentiment.

: SHL Telemedicine has higher revenue and earnings than Equillium.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
SHL Telemedicine $55.94M 0.60 -$7.06M N/A N/A
Equillium $41.10M 3.34 -$22.40M -$0.50 N/A
: SHL Telemedicine has a beta of 0.11, indicating that its share price is 89% less volatile than the S&P 500. Comparatively, Equillium has a beta of 1.67, indicating that its share price is 67% more volatile than the S&P 500.
: In the previous week, Equillium had 4 more articles in the media than SHL Telemedicine. MarketBeat recorded 4 mentions for Equillium and 0 mentions for SHL Telemedicine. Equillium's average media sentiment score of 0.75 beat SHL Telemedicine's score of 0.00 indicating that Equillium is being referred to more favorably in the news media.
Company Overall Sentiment
SHL Telemedicine Neutral
Equillium Positive
: Equillium has a consensus target price of $7.67, suggesting a potential upside of 253.30%. Given Equillium's stronger consensus rating and higher possible upside, analysts plainly believe Equillium is more favorable than SHL Telemedicine.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SHL Telemedicine
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Equillium
1 Sell rating(s)

1 Hold rating(s)

5 Buy rating(s)

1 Strong Buy rating(s)
2.75
: SHL Telemedicine's return on equity of 0.00% beat Equillium's return on equity.
Company Net Margins Return on Equity Return on Assets
SHL Telemedicine N/A N/A N/A
Equillium N/A -119.19% -93.79%
: 20.1% of SHL Telemedicine shares are owned by institutional investors. Comparatively, 27.1% of Equillium shares are owned by institutional investors. 17.8% of Equillium shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SHL Telemedicine	$55.94M	0.60	-$7.06M	N/A	N/A
Equillium	$41.10M	3.34	-$22.40M	-$0.50	N/A

Company	Overall Sentiment
SHL Telemedicine	Neutral
Equillium	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SHL Telemedicine	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Equillium	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.75

Company	Net Margins	Return on Equity	Return on Assets
SHL Telemedicine	N/A	N/A	N/A
Equillium	N/A	-119.19%	-93.79%

Summary

Equillium beats SHL Telemedicine on 10 of the 14 factors compared between the two stocks.

How does SHL Telemedicine compare to Immunic?

Immunic (NASDAQ:IMUX) and SHL Telemedicine (NASDAQ:SHLT) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends.

: SHL Telemedicine's return on equity of 0.00% beat Immunic's return on equity.
Company Net Margins Return on Equity Return on Assets
Immunic N/A -1,197.81% -264.95%
SHL Telemedicine N/A N/A N/A
: Immunic presently has a consensus price target of $52.43, indicating a potential upside of 375.76%. Given Immunic's stronger consensus rating and higher possible upside, equities research analysts clearly believe Immunic is more favorable than SHL Telemedicine.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Immunic
1 Sell rating(s)
1 Hold rating(s)

6 Buy rating(s)

3 Strong Buy rating(s)
3.00
SHL Telemedicine
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
: Immunic has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500. Comparatively, SHL Telemedicine has a beta of 0.11, indicating that its stock price is 89% less volatile than the S&P 500.
: In the previous week, Immunic had 12 more articles in the media than SHL Telemedicine. MarketBeat recorded 12 mentions for Immunic and 0 mentions for SHL Telemedicine. SHL Telemedicine's average media sentiment score of 0.00 beat Immunic's score of -0.06 indicating that SHL Telemedicine is being referred to more favorably in the news media.
Company Overall Sentiment
Immunic Neutral
SHL Telemedicine Neutral
: SHL Telemedicine has higher revenue and earnings than Immunic.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Immunic N/A N/A -$97.17M -$7.00 N/A
SHL Telemedicine $55.94M 0.60 -$7.06M N/A N/A
: 51.8% of Immunic shares are owned by institutional investors. Comparatively, 20.1% of SHL Telemedicine shares are owned by institutional investors. 14.0% of Immunic shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Company	Net Margins	Return on Equity	Return on Assets
Immunic	N/A	-1,197.81%	-264.95%
SHL Telemedicine	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Immunic	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	3 Strong Buy rating(s)	3.00
SHL Telemedicine	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Company	Overall Sentiment
Immunic	Neutral
SHL Telemedicine	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Immunic	N/A	N/A	-$97.17M	-$7.00	N/A
SHL Telemedicine	$55.94M	0.60	-$7.06M	N/A	N/A

Summary

Immunic beats SHL Telemedicine on 8 of the 13 factors compared between the two stocks.

How does SHL Telemedicine compare to Edap Tms?

SHL Telemedicine (NASDAQ:SHLT) and Edap Tms (NASDAQ:EDAP) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, dividends, valuation and earnings.

: Edap Tms has a consensus price target of $6.00, indicating a potential upside of 66.67%. Given Edap Tms' stronger consensus rating and higher possible upside, analysts plainly believe Edap Tms is more favorable than SHL Telemedicine.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SHL Telemedicine
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Edap Tms
1 Sell rating(s)

2 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
: 20.1% of SHL Telemedicine shares are held by institutional investors. Comparatively, 62.7% of Edap Tms shares are held by institutional investors. 0.2% of Edap Tms shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
: SHL Telemedicine has a net margin of 0.00% compared to Edap Tms' net margin of -41.24%. SHL Telemedicine's return on equity of 0.00% beat Edap Tms' return on equity.
Company Net Margins Return on Equity Return on Assets
SHL Telemedicine N/A N/A N/A
Edap Tms -41.24% -100.07% -37.38%
: SHL Telemedicine has a beta of 0.11, indicating that its stock price is 89% less volatile than the S&P 500. Comparatively, Edap Tms has a beta of -0.1, indicating that its stock price is 110% less volatile than the S&P 500.
: SHL Telemedicine has higher earnings, but lower revenue than Edap Tms.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
SHL Telemedicine $55.94M 0.60 -$7.06M N/A N/A
Edap Tms $70.53M 1.91 -$29.25M -$0.77 N/A
: In the previous week, Edap Tms had 3 more articles in the media than SHL Telemedicine. MarketBeat recorded 3 mentions for Edap Tms and 0 mentions for SHL Telemedicine. SHL Telemedicine's average media sentiment score of 0.00 equaled Edap Tms'average media sentiment score.
Company Overall Sentiment
SHL Telemedicine Neutral
Edap Tms Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SHL Telemedicine	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Edap Tms	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Net Margins	Return on Equity	Return on Assets
SHL Telemedicine	N/A	N/A	N/A
Edap Tms	-41.24%	-100.07%	-37.38%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SHL Telemedicine	$55.94M	0.60	-$7.06M	N/A	N/A
Edap Tms	$70.53M	1.91	-$29.25M	-$0.77	N/A

Company	Overall Sentiment
SHL Telemedicine	Neutral
Edap Tms	Neutral

Summary

Edap Tms beats SHL Telemedicine on 8 of the 13 factors compared between the two stocks.

How does SHL Telemedicine compare to Alpha Cognition?

SHL Telemedicine (NASDAQ:SHLT) and Alpha Cognition (NASDAQ:ACOG) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership and profitability.

: SHL Telemedicine has higher revenue and earnings than Alpha Cognition.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
SHL Telemedicine $55.94M 0.60 -$7.06M N/A N/A
Alpha Cognition $10.22M 13.59 -$20.67M -$1.16 N/A
: 20.1% of SHL Telemedicine shares are held by institutional investors. 14.0% of Alpha Cognition shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
: SHL Telemedicine has a net margin of 0.00% compared to Alpha Cognition's net margin of -202.23%. SHL Telemedicine's return on equity of 0.00% beat Alpha Cognition's return on equity.
Company Net Margins Return on Equity Return on Assets
SHL Telemedicine N/A N/A N/A
Alpha Cognition -202.23% -55.71% -43.78%
: In the previous week, Alpha Cognition had 3 more articles in the media than SHL Telemedicine. MarketBeat recorded 3 mentions for Alpha Cognition and 0 mentions for SHL Telemedicine. SHL Telemedicine's average media sentiment score of 0.00 equaled Alpha Cognition'saverage media sentiment score.
Company Overall Sentiment
SHL Telemedicine Neutral
Alpha Cognition Neutral
: SHL Telemedicine has a beta of 0.11, suggesting that its share price is 89% less volatile than the S&P 500. Comparatively, Alpha Cognition has a beta of 2.38, suggesting that its share price is 138% more volatile than the S&P 500.
: Alpha Cognition has a consensus target price of $16.00, suggesting a potential upside of 150.78%. Given Alpha Cognition's stronger consensus rating and higher probable upside, analysts clearly believe Alpha Cognition is more favorable than SHL Telemedicine.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SHL Telemedicine
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Alpha Cognition
0 Sell rating(s)

0 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
3.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SHL Telemedicine	$55.94M	0.60	-$7.06M	N/A	N/A
Alpha Cognition	$10.22M	13.59	-$20.67M	-$1.16	N/A

Company	Net Margins	Return on Equity	Return on Assets
SHL Telemedicine	N/A	N/A	N/A
Alpha Cognition	-202.23%	-55.71%	-43.78%

Company	Overall Sentiment
SHL Telemedicine	Neutral
Alpha Cognition	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SHL Telemedicine	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Alpha Cognition	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Alpha Cognition beats SHL Telemedicine on 7 of the 13 factors compared between the two stocks.

How does SHL Telemedicine compare to Apyx Medical?

Apyx Medical (NASDAQ:APYX) and SHL Telemedicine (NASDAQ:SHLT) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, media sentiment, analyst recommendations, earnings, risk and institutional ownership.

: In the previous week, Apyx Medical had 9 more articles in the media than SHL Telemedicine. MarketBeat recorded 9 mentions for Apyx Medical and 0 mentions for SHL Telemedicine. Apyx Medical's average media sentiment score of 0.67 beat SHL Telemedicine's score of 0.00 indicating that Apyx Medical is being referred to more favorably in the media.
Company Overall Sentiment
Apyx Medical Positive
SHL Telemedicine Neutral
: Apyx Medical currently has a consensus target price of $6.50, suggesting a potential upside of 122.60%. Given Apyx Medical's stronger consensus rating and higher possible upside, equities research analysts plainly believe Apyx Medical is more favorable than SHL Telemedicine.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Apyx Medical
1 Sell rating(s)
1 Hold rating(s)

3 Buy rating(s)

1 Strong Buy rating(s)
2.67
SHL Telemedicine
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
: Apyx Medical has a beta of 1.35, indicating that its share price is 35% more volatile than the S&P 500. Comparatively, SHL Telemedicine has a beta of 0.11, indicating that its share price is 89% less volatile than the S&P 500.
: 55.3% of Apyx Medical shares are owned by institutional investors. Comparatively, 20.1% of SHL Telemedicine shares are owned by institutional investors. 15.2% of Apyx Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
: SHL Telemedicine has a net margin of 0.00% compared to Apyx Medical's net margin of -21.22%. SHL Telemedicine's return on equity of 0.00% beat Apyx Medical's return on equity.
Company Net Margins Return on Equity Return on Assets
Apyx Medical -21.22% -114.95% -18.49%
SHL Telemedicine N/A N/A N/A
: SHL Telemedicine has higher revenue and earnings than Apyx Medical.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Apyx Medical $52.84M 2.31 -$11.21M -$0.27 N/A
SHL Telemedicine $55.94M 0.60 -$7.06M N/A N/A

Company	Overall Sentiment
Apyx Medical	Positive
SHL Telemedicine	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67
SHL Telemedicine	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-21.22%	-114.95%	-18.49%
SHL Telemedicine	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.84M	2.31	-$11.21M	-$0.27	N/A
SHL Telemedicine	$55.94M	0.60	-$7.06M	N/A	N/A

Summary

Apyx Medical beats SHL Telemedicine on 10 of the 15 factors compared between the two stocks.

Get SHL Telemedicine News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SHLT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SHLT vs. The Competition

Export

Metric	SHL Telemedicine	Offices & clinics of medical doctors Industry	Medical Sector	NASDAQ Exchange
Market Cap	$33.61M	$57.79M	$6.28B	$11.90B
Dividend Yield	N/A	N/A	2.74%	5.26%
P/E Ratio	N/A	N/A	29.17	27.35
Price / Sales	0.60	N/A	525.50	85.51
Price / Cash	54.03	N/A	43.42	54.56
Price / Book	0.39	N/A	9.82	6.79
Net Income	-$7.06M	-$8.34M	$3.55B	$332.68M

SHL Telemedicine Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SHLT SHL Telemedicine	N/A	$2.05 flat	N/A	N/A	$33.61M	$55.94M	N/A	583
EQ Equillium	3.1399 of 5 stars	$2.08 +2.0%	$7.67 +268.6%	+484.9%	$131.51M	$41.10M	N/A	40	Upcoming Earnings
IMUX Immunic	2.9752 of 5 stars	$9.65 +0.3%	$52.43 +443.3%	+3.5%	$131.44M	N/A	N/A	70	Analyst Upgrade Analyst Revision
EDAP Edap Tms	2.286 of 5 stars	$3.47 +4.5%	$6.00 +72.9%	+67.4%	$130.06M	$70.53M	N/A	230	News Coverage
ACOG Alpha Cognition	2.8599 of 5 stars	$5.95 -0.3%	$16.00 +168.9%	-8.3%	$129.56M	$10.22M	N/A	N/A	Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SHLT) was last updated on 5/7/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SHL Telemedicine (SHLT) Competitors

SHLT vs. EQ, IMUX, EDAP, ACOG, and APYX

How does SHL Telemedicine compare to Equillium?

Summary

How does SHL Telemedicine compare to Immunic?

Summary

How does SHL Telemedicine compare to Edap Tms?

Summary

How does SHL Telemedicine compare to Alpha Cognition?

Summary

How does SHL Telemedicine compare to Apyx Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SHLT vs. The Competition

SHL Telemedicine Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

SHL Telemedicine (SHLT) Competitors

SHLT vs. EQ, IMUX, EDAP, ACOG, and APYX

How does SHL Telemedicine compare to Equillium?

Summary

How does SHL Telemedicine compare to Immunic?

Summary

How does SHL Telemedicine compare to Edap Tms?

Summary

How does SHL Telemedicine compare to Alpha Cognition?

Summary

How does SHL Telemedicine compare to Apyx Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SHLT vs. The Competition

SHL Telemedicine Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools